Published in Obesity and Diabetes Week, May 24th, 2010
Unique as a weight loss procedure, gastric imbrication is a reversible procedure with no device required to be implanted and no stomach tissue removed. With over 200,000 people engaging in surgical weight loss procedures annually in the United States the appeal and potential for such a procedure is significant.
Crospon participated as part of a randomized control trial currently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.